207 related articles for article (PubMed ID: 21571403)
21. In vitro antileishmanial effects of Physalis angulata root extract on Leishmania infantum.
Da Silva BJM; Pereira SWG; Rodrigues APD; Do Nascimento JLM; Silva EO
J Integr Med; 2018 Nov; 16(6):404-410. PubMed ID: 30195443
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
23. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
Bhattacharya A; Ouellette M
EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
[No Abstract] [Full Text] [Related]
24. Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives.
Calogeropoulou T; Angelou P; Detsi A; Fragiadaki I; Scoulica E
J Med Chem; 2008 Feb; 51(4):897-908. PubMed ID: 18220332
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
26. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.
Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P
Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania (Leishmania) infantum chagasi.
Brasil PF; de Freitas JA; Barreto ALS; Adade CM; Reis de Sá LF; Constantino-Teles P; Toledo FT; de Sousa BA; Gonçalves AC; Romanos MTV; Comasseto JV; Dos Santos AA; Tessis AC; Souto-Padrón T; Soares RMA; Ferreira-Pereira A
Parasitol Int; 2017 Apr; 66(2):47-55. PubMed ID: 27888011
[TBL] [Abstract][Full Text] [Related]
29. Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
Alzate JF; Arias A; Mollinedo F; Rico E; de la Iglesia-Vicente J; Jiménez-Ruiz A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3779-82. PubMed ID: 18644968
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
32. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Leishmanicidal Activity of Novel Urea, Thiourea, and Selenourea Derivatives of Diselenides.
Díaz M; de Lucio H; Moreno E; Espuelas S; Aydillo C; Jiménez-Ruiz A; Toro MÁ; Gutiérrez KJ; Martínez-Merino V; Cornejo A; Palop JA; Sanmartín C; Plano D
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782984
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives.
Germonprez N; Maes L; Van Puyvelde L; Van Tri M; Tuan DA; De Kimpe N
J Med Chem; 2005 Jan; 48(1):32-7. PubMed ID: 15633999
[TBL] [Abstract][Full Text] [Related]
36. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds.
Paloque L; Bouhlel A; Curti C; Dumètre A; Verhaeghe P; Azas N; Vanelle P
Eur J Med Chem; 2011 Jul; 46(7):2984-91. PubMed ID: 21555166
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.
Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM
J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160
[TBL] [Abstract][Full Text] [Related]
39. Discovery of new organoselenium compounds as antileishmanial agents.
Al-Tamimi AS; Etxebeste-Mitxeltorena M; Sanmartín C; Jiménez-Ruiz A; Syrjänen L; Parkkila S; Selleri S; Carta F; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():339-345. PubMed ID: 30743174
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides.
Nie Y; Zhong M; Li S; Li X; Zhang Y; Zhang Y; He X
Chem Biodivers; 2020 May; 17(5):e1900603. PubMed ID: 32198823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
